U.S. Construction Stock News

NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

A Look At GE HealthCare Technologies (GEHC) Valuation After New FDA Clearances For MRI Offerings

GE HealthCare Technologies (GEHC) is back in focus after securing 510(k) FDA clearance for three MRI offerings, including a helium free system, a high performance 3T scanner and an AI centered workflow platform. See our latest analysis for GE HealthCare Technologies. Despite the fresh MRI clearances and a series of recent agreements in ultrasound, imaging alliances and new credit facilities, GE HealthCare’s recent momentum has been mixed, with a 1 month share price return of 1.51% but a 1...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise Targets AI Growth With Juniper Integration Push

Hewlett Packard Enterprise (NYSE:HPE) has introduced new AI native networking and compute solutions ahead of Mobile World Congress 2026. The launch includes expanded integration of Juniper Networks technology across HPE's networking portfolio. HPE is pairing these AI focused offerings with new financing options aimed at service providers scaling AI infrastructure and modern networks. Hewlett Packard Enterprise, trading at $22.13, is putting fresh attention on AI centric networking and...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

nLIGHT Laser Weapon Showcase Fuels Defense Story And Valuation Debate

nLIGHT (NasdaqGS:LASR) is set to showcase its next generation high energy laser weapon systems at the upcoming POST Conference. The company plans to present a newly developed 70kW class system alongside advanced 30kW and 10kW High Energy Lasers for defense use. The event highlights nLIGHT's growing role in mission critical applications for U.S. and allied defense stakeholders. For investors watching nLIGHT, the POST Conference comes at a time when the stock has shown very strong momentum,...
NYSE:F
NYSE:FAuto

Ford Recalls Put Spotlight On EV Profit Goals And Investor Trade Offs

Ford Motor (NYSE:F) has issued major recalls affecting millions of vehicles due to safety issues with rear suspension toe links. The company is also addressing a software flaw tied to braking performance and exterior lighting in several key models. Alongside the recalls, Ford has updated its electric vehicle plans, targeting profitability for its EV division by 2029. Ford aims for meaningful growth in global electric vehicle volume by 2030, describing the recalls and EV timeline as part of a...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

Is U.S. Gold (USAU) Using Its Conference Spotlight To Recast Management Credibility With Investors?

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora Innovation (AUR) Valuation Check As Board Changes Put Governance In The Spotlight

Board changes put Aurora Innovation (AUR) governance in focus Aurora Innovation (AUR) is back on investor watch after director Claire D’Oyly-Hughes Johnson resigned on February 27, 2026, and Meta executive David Wehner joined the board to deepen governance and financial oversight. See our latest analysis for Aurora Innovation. The board reshuffle comes as Aurora Innovation’s share price, now at $4.75, has logged a 13.1% 1 month share price return and a 19.1% 3 month share price return, while...
NYSE:PHM
NYSE:PHMConsumer Durables

How Investors Are Reacting To PulteGroup (PHM) Launching Its $300 Million Hilliard Isle Community

PulteGroup recently presented at the 47th Annual Raymond James Institutional Investor Conference and, through Pulte Homes, has broken ground on Hilliard Isle, a US$300 million, 900-acre master-planned community in Kissimmee featuring more than 2,000 homes and extensive resort-style amenities. These developments come as PulteGroup contends with slowing orders, margin pressure, and a declining backlog, while still outperforming recent earnings expectations through what management describes as...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

A Look At LKQ (LKQ) Valuation As Activist-Driven Business Review Raises Sale Prospects

LKQ (LKQ) has initiated a formal review of its business after renewed pressure from activist investors, putting potential asset sales or even a full company sale on the table for shareholders. See our latest analysis for LKQ. LKQ's formal review comes after a tough run for long term holders, with a 1 year total shareholder return decline of 19.3% and a 3 year total shareholder return decline of 38.1%. At the same time, the 90 day share price return of 12.3% suggests momentum has recently...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

Could WD-40 (WDFC) Strengthen Governance Without Shifting Its Core Capital Allocation Priorities?

WD-40 Company recently expanded its board of directors to 10 members by appointing Ken Plunk, a former J&J Snack Foods chief financial officer and long-time Wal-Mart executive, to serve on its Audit and Finance Committees effective February 18, 2026. This appointment brings extensive financial, international operations, and risk oversight experience to WD-40’s board, potentially strengthening governance around capital allocation, global expansion, and operational efficiency. Next, we’ll...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS

In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$507.44 million for the year, alongside a larger net loss and a US$112,867,000 impairment of intangible assets, and it also issued 2026 net sales guidance of US$600 million to US$620 million. Glaukos has also filed a US$69.25 million shelf registration tied to an ESOP-related common stock offering, highlighting how the company is...
NYSE:AWI
NYSE:AWIBuilding

A Look At Armstrong World Industries (AWI) Valuation After 2025 Results And 2026 Earnings Guidance

Why Armstrong World Industries is on investors’ radar right now Armstrong World Industries (AWI) has attracted fresh attention after releasing fourth quarter and full year 2025 results alongside earnings guidance for 2026, giving investors new data on both recent performance and management expectations. See our latest analysis for Armstrong World Industries. The recent guidance for 2026, dividend affirmation and senior leadership change come as the share price has pulled back, with a 7 day...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV) Is Down 20.3% After Landing $186 Million Army Switchblade Order - Has The Bull Case Changed?

In late February 2026, AeroVironment announced a US$186 million delivery order from the U.S. Army for its next-generation Switchblade 600 Block 2 and Switchblade 300 Block 20 loitering munitions under an existing five-year, US$990 million IDIQ contract for Lethal Unmanned Systems. This marks the Army’s first procurement of AeroVironment’s upgraded Switchblade line featuring explosively formed penetrator payloads and enhanced anti-armor capabilities, reinforcing the company’s role in...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Did IDEAYA’s (IDYA) First-in-Human IDE034 Trial Just Redefine Its Targeted Oncology Strategy?

IDEAYA Biosciences recently enrolled the first patient in a Phase 1 trial of IDE034, a bispecific TOP1 antibody-drug conjugate targeting co-expressed PTK7 and B7H3 in solid tumors, triggering a US$5.00 million milestone payment to Biocytogen under their Option and License Agreement. The trial positions IDE034 as a potentially first-in-class asset with a co-expression-based targeting approach and combination plans with IDEAYA’s PARG inhibitor IDE161, aimed at enhancing selectivity and...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

How iTero–Henry Schein One Integration and New Bylaws Will Impact Align Technology (ALGN) Investors

In February 2026, Henry Schein One announced a direct data integration between Align Technology’s iTero intraoral scanners and its Dentrix, Dentrix Ascend, and Dentally practice management platforms, while Align’s board separately adopted amended and restated bylaws allowing long-term holders of at least 25% of its shares to request special shareholder meetings. Together, the deeper integration of iTero into one of dentistry’s largest software ecosystems and the expanded shareholder meeting...
NYSE:DIS
NYSE:DISEntertainment

Assessing Disney (DIS) Valuation As Recent Share Weakness Meets Conflicting Undervaluation Signals

Recent Performance Snapshot Walt Disney (DIS) has seen mixed share performance recently, with about a 1.6% decline over the past day, flat movement over the past week, and a larger decline over the past month. See our latest analysis for Walt Disney. Looking beyond the recent weakness, the 1 year total shareholder return is a decline of 6.5%, while the 3 year total shareholder return is a gain of 6.1%. This suggests sentiment has been improving over a longer stretch, even as the current share...
NYSE:CHD
NYSE:CHDHousehold Products

Assessing Church & Dwight (CHD) Valuation After Recent Share Price Momentum And Mixed Return Profile

Why Church & Dwight is on investors’ radar today Church & Dwight (CHD) is drawing fresh attention after a period in which the share price and fundamentals have moved in different directions, prompting investors to reassess how the business is currently priced. The stock has returned about 8% over the past month and roughly 24% in the past 3 months, while the 1 year total return is a 6% decline. That split between recent momentum and longer term performance often leads investors to look more...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie Expands Rare Oncology And Immunology With New U.S. Manufacturing Investment

AbbVie (NYSE:ABBV) received FDA orphan drug designation for a neuroendocrine carcinoma treatment. The company reported positive Phase 3 results for risankizumab in Crohn's disease. AbbVie announced a $380 million investment in new U.S. manufacturing facilities using advanced technologies and AI. AbbVie, trading at $234.26, has seen its share price move alongside a 14.5% return over the past year and a 167.3% return over the past five years. These recent updates touch three key areas...
NYSE:FR
NYSE:FRIndustrial REITs

Is Activist Land & Buildings’ Boardroom Challenge Altering The Investment Case For First Industrial Realty Trust (FR)?

In February 2026, activist investor Land & Buildings intensified pressure on First Industrial Realty Trust by publicly criticizing the board’s culture, urging governance and portfolio changes, and formally nominating its founder Jonathan Litt for election at the 2026 annual shareholder meeting. This push for boardroom reform comes just after First Industrial reported quarterly earnings and revenue that significantly exceeded analyst expectations, sharpening attention on how governance...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Assessing Henry Schein (HSIC) Valuation After Recent Share Price Momentum

Why Henry Schein is on investors' radar today Henry Schein (HSIC) has drawn fresh attention after its recent trading performance, with the shares closing at $81.37 and showing positive returns over the past month and the past three months. See our latest analysis for Henry Schein. While the share price saw a 1 day decline of 1.24%, Henry Schein’s 30 day share price return of 7.80% and 1 year total shareholder return of 14.91% suggest momentum has been building recently rather than fading. If...
NYSE:ALG
NYSE:ALGMachinery

Assessing Alamo Group (ALG) Valuation After Weaker 2025 Earnings And Strong Recent Share Gains

Why the latest earnings matter for Alamo Group (ALG) Alamo Group (ALG) drew fresh attention after reporting fourth quarter and full year 2025 results, showing lower sales and net income than the prior year. This combination can reshape how investors think about the stock. See our latest analysis for Alamo Group. Despite the weaker 2025 earnings print, Alamo Group’s share price has been strong, with a 90 day share price return of 34.94% and a 1 year total shareholder return of 24.93%. This...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Should Capital Clean Energy Carriers’ €250 Million Bond and 2025 Results Timing Require Action From CCEC Investors?

Capital Clean Energy Carriers Corp. recently priced a €250 million unsecured bond issue in Greece, maturing in 2033 with a 3.75% semi-annual coupon, and has also announced that its fourth-quarter 2025 financial results will be released on March 5, 2026. The bond proceeds earmarked for debt repayment, capital expenditure and working capital shed light on how CCEC is reshaping its balance sheet and funding future growth projects. We’ll explore how this €250 million unsecured bond issuance may...
NYSE:DTM
NYSE:DTMOil and Gas

What DT Midstream (DTM)'s Strong 2025 Results and Bigger Project Pipeline Mean For Shareholders

DT Midstream, Inc. reported full-year 2025 results showing sales rising to US$1,243 million and net income to US$441 million, alongside a 7% dividend increase to US$0.88 per share and a US$396.99 million shelf registration for 3,000,000 shares related to its ESOP. Management’s disclosure that its project pipeline is several times larger than the announced US$3.40 billion capital plan, with growth expected to outpace a 7% annualized rate through the rest of the decade, points to a materially...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Valuation After Earnings Miss And Margin Pressure From Heavy Growth Investments

Why MercadoLibre’s earnings triggered such a strong stock reaction MercadoLibre (MELI) reported fourth quarter 2025 revenue of US$8.76b and net income of US$559m, a result that paired strong business activity with higher spending and thinner margins. For the full year 2025, revenue reached US$28.89b and net income was US$1.997b, with earnings per share from continuing operations at US$39.40 on both a basic and diluted basis. See our latest analysis for MercadoLibre. MercadoLibre’s recent...
NYSE:SGHC
NYSE:SGHCHospitality

Super Group (SGHC) Is Up 13.4% After Strong 2025 Results And Higher Dividend Guidance

Super Group (SGHC) Limited recently reported strong fourth-quarter and full-year 2025 results, lifting annual revenue from US$1.80 billion in 2024 to US$2.20 billion, while guiding for 2026 revenue above US$2.55 billion and confirming plans to raise its annual dividend program target to a minimum of US$0.20 per share, payable quarterly from March 31, 2026. An interesting aspect is how broad-based regional growth across Europe, Asia-Pacific, Africa, and North America is coinciding with a...